查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083872

男性健康診斷市場：2026-2032年全球市場預測（按診斷類型、測試類型、檢體類型、應用程式和最終用戶分類）

Mens Health Diagnostics Market by Diagnostic Type, Test Type, Sample Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，男性健康診斷市場將成長至 352.9 億美元，複合年成長率為 11.69%。

主要市場統計數據
基準年 2025 162.7億美元
預計年份：2026年 181.5億美元
預測年份 2032 352.9億美元
複合年成長率 (%) 11.69%

男性健康診斷市場正從傳統的僅限於泌尿系統症狀就診的模式，轉向更廣泛的、循證的模式，以支持預防醫學、早期檢測、慢性病管理、生育力評估、性健康和健康老化。此領域涵蓋臨床化學、免疫檢測、分子診斷、影像學、數位化風險分層、居家檢體採集以及伴隨診斷路徑，應用於前列腺健康、性腺功能減退、心血管風險、代謝紊亂、性行為感染感染和男性不孕症等領域。

該領域的需求在臨床上十分迫切。來自世界各地衛生組織的報告一致表明，在大多數國家，男性的預期壽命比女性短，且較少利用預防性醫療保健服務。同時，攝護腺癌仍然是全球男性最常見的癌症之一，而且隨著人們對糖尿病、肥胖、心血管疾病和生殖健康的日益關注，對便捷、準確且以患者為中心的診斷解決方案的需求也在不斷成長。

診斷領域的變革性變化

男性健康診斷領域正受到三大相互關聯的變革的影響而重塑：早期療育、分散式檢查和精準醫療。傳統的碎片化檢測正轉向長期健康監測，將檢測數據、影像學檢查、風險評分、家族病史和生活方式指標相結合，從而實現疾病的早期發現，並有助於制定個人化的治療方案。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過提高工作流程效率、風險預測和臨床決策支持，在男性健康診斷領域發揮協同效應。在前列腺醫學領域，人工智慧驅動的工具正被評估和應用，用於前列腺磁振造影 (MRI) 解讀、數位病理學、病灶檢測、切片檢查引導和預後建模。在實驗室操作中，人工智慧正在支援品管、異常檢測、工作流程優先排序和快速結果溝通。

關鍵區域洞察

亞太地區是男性健康診斷領域最具活力的地區之一，這主要得益於其龐大的人口基數、快速的都市化、私人醫療保健的擴張，以及中國、印度、日本、韓國和澳洲慢性病檢出率的不斷提高。在日本、中國、韓國和澳大利亞，人口老化推動了對前列腺健康、心臟代謝和荷爾蒙相關檢測需求的成長。同時，在印度，其龐大的人口規模和完善的公共數位醫療基礎設施正在改善人們獲得檢查室和遠距醫療服務的途徑。

主要群體趨勢

在東南亞國協，男性健康診斷市場正因全民健保體系的普及、私立醫院的蓬勃發展、醫療旅遊的興起以及檢測網路的完善等多種因素而不斷擴張。儘管新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的成熟度有所不同，但對心臟代謝篩檢、不孕症檢測、性行為感染（STI）診斷和癌症篩檢的需求通用且持續成長。

主要國家的概況

美國在先進診斷、泌尿系統創新、分子檢測和人工智慧成像領域處於主導。加拿大則透過其省級醫療保健系統，強調實證醫學的應用。墨西哥和巴西是拉丁美洲的重要市場，這得益於私人實驗室網路、都市區專科醫療以及對癌症和代謝疾病檢測日益成長的需求。在歐洲，儘管人口老化，英國、德國、法國、義大利和西班牙仍建立了腫瘤和基層醫療保健相結合的診療路徑。同時，儘管面臨供應和技術方面的限制，俄羅斯對泌尿系統和慢性病診斷的需求依然強勁。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的診斷路徑，將PSA檢測、前列腺MRI、分子診斷工具、荷爾蒙水平檢測、生育力評估、心臟代謝篩檢和數位化風險分層整合到一個統一的男性健康計畫中。解決方案的設計應涵蓋基層醫療、泌尿系統、腫瘤科和消費者等不同場景，並就檢測結果如何影響臨床決策提供清晰的指南。

調查方法

本執行摘要基於結構化的研究途徑，結合了二手資訊分析、監管審查、臨床指南評估和市場訊號三角驗證。主要參考文獻包括世界衛生組織 (WHO)、國際癌症研究機構 (IARC)、經濟合作暨發展組織(OECD)、世界銀行、各國衛生組織以及美國食品藥物管理局(FDA) 和歐盟委員會等權威監管機構的公開資料集和出版物。

結論

隨著預防醫學、精準醫療、居家檢測的普及以及人工智慧驅動的工作流程的融合，男性健康診斷領域正經歷著快速變革時期。推動這項變革的因素包括男性人口老化、慢性疾病負擔持續加重、人們對攝護腺和生殖健康意識的提高，以及從早期階段就關注男性健康的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 男性健康診斷市場：依診斷類型分類

  • 荷爾蒙診斷
  • 不孕症和生殖診斷
  • 精神和神經系統疾病的生物標記
  • 代謝和一般健康篩檢

第8章：男性健康診斷市場：依檢測類型分類

  • 影像系統
    • 電腦斷層掃描（CT）
    • 磁振造影（MRI）
    • 核醫學影像
    • 超音波
    • X光
  • 臨床試驗
    • 生物標記檢測
    • 基因檢測

第9章：男性健康診斷市場：依樣本類型分類

  • 血
  • 尿
  • 精液
  • 唾液

第10章：男性健康診斷市場：依應用領域分類

  • 心血管診斷
  • 糖尿病監測
  • 前列腺癌診斷
  • 泌尿系統疾病的診斷

第11章 男性健康診斷市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院

第12章 男性健康診斷市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：男性健康診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 男性健康診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • A3P Biomedical AB
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • DiaSorin SpA
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • Horiba Ltd.
  • Johnson & Johnson Service, Inc.
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Minomic International Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Opko Health, Inc.
  • ProteoMediX AG
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-431388EE3BC2

The Mens Health Diagnostics Market is projected to grow by USD 35.29 billion at a CAGR of 11.69% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 16.27 billion
Estimated Year [2026] USD 18.15 billion
Forecast Year [2032] USD 35.29 billion
CAGR (%) 11.69%

Men's health diagnostics is moving from a narrow focus on symptomatic urology visits to a broader, evidence-driven model that supports preventive care, early detection, chronic disease management, fertility assessment, sexual health, and healthy aging. The category includes clinical chemistry, immunoassays, molecular diagnostics, imaging, digital risk stratification, at-home sample collection, and companion diagnostic pathways used across prostate health, hypogonadism, cardiovascular risk, metabolic disease, sexually transmitted infections, and male infertility.

The need is clinically urgent. Global health agencies consistently show that men have lower life expectancy than women in most countries and are less likely to use preventive healthcare services. At the same time, prostate cancer remains one of the most commonly diagnosed cancers among men worldwide, while diabetes, obesity, cardiovascular disease, and reproductive health concerns continue to increase demand for accessible, accurate, and patient-centered diagnostic solutions.

Transformative Shifts in the Diagnostics Landscape

The men's health diagnostics landscape is being reshaped by three connected shifts: earlier intervention, decentralized testing, and precision-guided care. Traditional, episodic testing is giving way to longitudinal health monitoring that combines laboratory data, imaging, risk scores, family history, and lifestyle indicators to identify disease earlier and guide personalized treatment decisions.

Regulatory and reimbursement environments are also changing. The European Union's In Vitro Diagnostic Regulation is raising evidence and quality expectations for diagnostic developers, while the United States is increasing oversight of laboratory-developed tests. These developments favor organizations with strong clinical validation, transparent analytical performance, cybersecurity controls, and real-world evidence strategies. Digital health, telemedicine, and at-home collection are further expanding access, particularly for men who delay clinic-based care due to stigma, time constraints, or limited local specialist availability.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across men's health diagnostics by improving workflow efficiency, risk prediction, and clinical decision support. In prostate care, AI-enabled tools are being evaluated and adopted for prostate MRI interpretation, digital pathology, lesion detection, biopsy guidance, and prognostic modeling. In laboratory operations, AI supports quality control, anomaly detection, workflow prioritization, and faster result routing.

The highest-value use cases are not replacements for clinicians; they are systems that reduce variation, surface high-risk patients earlier, and support shared decision-making. However, adoption depends on explainability, prospective validation, bias monitoring, privacy compliance, and integration with electronic health records. Organizations that pair AI with rigorous governance can create measurable advantages in diagnostic accuracy, turnaround time, and patient engagement.

Key Regional Insights

Asia-Pacific is one of the most dynamic regions for men's health diagnostics, supported by large populations, rapid urbanization, expanding private healthcare, and rising chronic disease detection in China, India, Japan, South Korea, and Australia. Aging demographics in Japan, China, South Korea, and Australia are increasing demand for prostate health, cardiometabolic, and hormone-related testing, while India's scale and public digital health infrastructure are improving access to laboratory and teleconsultation services.

North America remains a leading region because of advanced laboratory networks, high diagnostic awareness, strong urology and oncology care pathways, and broad use of preventive testing in the United States and Canada. Latin America is advancing through private diagnostic chains and public health modernization, with Brazil and Mexico representing important demand centers despite uneven access. Europe benefits from aging populations, structured cancer pathways, and high clinical standards, while IVDR compliance is reshaping supplier strategies. The Middle East, especially the Gulf states, is investing in specialty care, screening, and digital health infrastructure. Africa remains underpenetrated but presents long-term potential through mobile health models, infectious disease testing infrastructure, and expanding urban diagnostic capacity.

Key Group Insights

ASEAN countries are expanding men's health diagnostics through a combination of universal coverage programs, private hospital growth, medical tourism, and improving laboratory networks. Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines show different levels of maturity, but shared demand is rising for cardiometabolic screening, fertility testing, STI diagnostics, and cancer detection.

The GCC is a high-priority group due to elevated chronic disease burdens, strong healthcare investment, and national transformation programs that prioritize preventive care and digital health. The European Union is defined by harmonized but more demanding regulatory expectations under IVDR and strong data protection under GDPR. BRICS economies offer scale, manufacturing localization, and expanding middle-class demand, although access varies by reimbursement, infrastructure, and regulatory pathways. G7 countries remain central for innovation, clinical validation, and premium diagnostic adoption. NATO is not a healthcare trade bloc, but its member countries increasingly influence diagnostic supply chain resilience, cybersecurity expectations, and emergency preparedness standards.

Key Country Insights

The United States leads in advanced diagnostics, urology innovation, molecular testing, and AI-enabled imaging, while Canada emphasizes evidence-based adoption through provincial health systems. Mexico and Brazil are important Latin American markets, driven by private laboratory networks, urban specialist care, and rising demand for cancer and metabolic testing. In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging populations with established oncology and primary care pathways, while Russia retains demand for urology and chronic disease diagnostics despite supply and technology constraints.

China and India offer the largest volume opportunities, supported by expanding hospital systems, digital health adoption, and increasing awareness of preventive testing. Japan, South Korea, and Australia are mature Asia-Pacific markets with strong screening cultures, advanced imaging, and high-quality laboratory infrastructure. South Korea's routine health checkup ecosystem and Japan's aging society make both countries important for early detection, while Australia combines public health programs with a sophisticated private diagnostics sector.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated diagnostic pathways that connect PSA testing, prostate MRI, molecular tools, hormone panels, fertility assessment, cardiometabolic screening, and digital risk stratification into coherent men's health programs. Solutions should be designed for primary care, urology, oncology, and consumer-access settings, with clear guidance on when testing changes clinical decisions.

Commercial success will depend on regulatory readiness, reimbursement evidence, and patient experience. Organizations should invest in real-world evidence, AI governance, interoperable data systems, and privacy-first digital engagement. Partnerships with urologists, employers, pharmacies, telehealth providers, and regional laboratory networks can improve access and adherence. In emerging markets, affordability, sample logistics, and localized education are as important as technology performance.

Research Methodology

This executive summary is built on a structured research approach combining secondary source analysis, regulatory review, clinical guideline assessment, and market signal triangulation. Core references include public datasets and publications from the World Health Organization, International Agency for Research on Cancer, OECD, World Bank, national health agencies, and recognized regulatory authorities such as the U.S. FDA and European Commission.

The methodology emphasizes verified, data-backed insights rather than unsubstantiated market claims. Findings are evaluated across disease burden, demographic trends, regulatory change, reimbursement dynamics, healthcare infrastructure, diagnostic technology adoption, and competitive positioning. Qualitative interpretation is aligned with standards for executive-level market intelligence, including cross-validation of regional and country-level assumptions.

Conclusion

Men's health diagnostics is entering a period of accelerated transformation as preventive care, precision medicine, at-home access, and AI-enabled workflows converge. Demand is supported by aging male populations, persistent chronic disease burdens, increased awareness of prostate and reproductive health, and the need to reach men earlier in the care journey.

The strongest opportunities will favor organizations that combine clinical credibility with scalable access. Organizations that validate their tests, integrate data responsibly, adapt to regional regulatory requirements, and build patient-centered diagnostic pathways will be best positioned to support long-term growth in this evolving field.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Mens Health Diagnostics Market, by Diagnostic Type

  • 7.1. Hormonal Diagnostics
  • 7.2. Fertility & Reproductive Diagnostics
  • 7.3. Mental & Neurological Health Biomarkers
  • 7.4. Metabolic & General Health Screening

8. Mens Health Diagnostics Market, by Test Type

  • 8.1. Imaging Systems
    • 8.1.1. Computed Tomography
    • 8.1.2. Magnetic Resonance Imaging
    • 8.1.3. Nuclear Imaging
    • 8.1.4. Ultrasound
    • 8.1.5. X Ray
  • 8.2. Laboratory Tests
    • 8.2.1. Biomarker Assays
    • 8.2.2. Genetic Testing

9. Mens Health Diagnostics Market, by Sample Type

  • 9.1. Blood
  • 9.2. Urine
  • 9.3. Semen
  • 9.4. Saliva

10. Mens Health Diagnostics Market, by Application

  • 10.1. Cardiovascular Diagnostics
  • 10.2. Diabetes Monitoring
  • 10.3. Prostate Cancer Diagnostics
  • 10.4. Urological Disorder Diagnostics

11. Mens Health Diagnostics Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals

12. Mens Health Diagnostics Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Mens Health Diagnostics Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Mens Health Diagnostics Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. A3P Biomedical AB
  • 16.2. Abbott Laboratories
  • 16.3. Agilent Technologies, Inc.
  • 16.4. Becton Dickinson and Company
  • 16.5. Bio-Rad Laboratories, Inc.
  • 16.6. bioMerieux SA
  • 16.7. Danaher Corporation
  • 16.8. DiaSorin S.p.A.
  • 16.9. Exact Sciences Corporation
  • 16.10. F. Hoffmann-La Roche Ltd
  • 16.11. Hologic, Inc.
  • 16.12. Horiba Ltd.
  • 16.13. Johnson & Johnson Service, Inc.
  • 16.14. Koninklijke Philips N.V.
  • 16.15. Mindray Medical International Limited
  • 16.16. Minomic International Ltd.
  • 16.17. Myriad Genetics, Inc.
  • 16.18. Natera, Inc.
  • 16.19. Opko Health, Inc.
  • 16.20. ProteoMediX AG
  • 16.21. QIAGEN N.V.
  • 16.22. Quest Diagnostics Incorporated
  • 16.23. Randox Laboratories Ltd.
  • 16.24. Siemens Healthineers AG
  • 16.25. Sonic Healthcare Limited
  • 16.26. Sysmex Corporation
  • 16.27. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL MENS HEALTH DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HORMONAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HORMONAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HORMONAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY & REPRODUCTIVE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY & REPRODUCTIVE DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY & REPRODUCTIVE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MENTAL & NEUROLOGICAL HEALTH BIOMARKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MENTAL & NEUROLOGICAL HEALTH BIOMARKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MENTAL & NEUROLOGICAL HEALTH BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL METABOLIC & GENERAL HEALTH SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL METABOLIC & GENERAL HEALTH SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL METABOLIC & GENERAL HEALTH SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COMPUTED TOMOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL X RAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL X RAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL X RAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LABORATORY TESTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LABORATORY TESTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOMARKER ASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOMARKER ASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOMARKER ASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SEMEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SEMEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SEMEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIOVASCULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIABETES MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIABETES MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIABETES MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGICAL DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 145. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GCC MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 169. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. G7 MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 177. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. NATO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 193. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 194. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 201. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 202. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. MEXICO MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 209. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 210. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. BRAZIL MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED KINGDOM MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 225. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 226. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. GERMANY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 233. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 234. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 236. FRANCE MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 241. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 242. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 249. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 250. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 252. ITALY MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 257. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 258. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. SPAIN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 273. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 274. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 277. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 281. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 282. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. JAPAN MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 290. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. AUSTRALIA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 293. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 297. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY LABORATORY TESTS, 2018-2032 (USD MILLION)
  • TABLE 298. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 300. SOUTH KOREA MENS HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)